Acceptability of and attitudes to the therapeutic use of cannabis and cannabidiol in people with Parkinson’s disease: A French survey

Tangui Barré, Géraldine Cazorla, Vincent Di Beo, Fabienne Lopez, Lise Radoszycki, Gwenaëlle Maradan, Christelle Baunez, Patrizia Carrieri · 2024

Read Acceptability of and attitudes to the therapeutic use of cannabis and cannabidiol in people with Parkinson’s disease: A French survey by Tangui Barré, Géraldine Cazorla, Vincent Di Beo, Fabienne Lopez, Lise Radoszycki, Gwenaëlle Maradan, Christelle Baunez, Patrizia Carrieri (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11647636.txt.

Description

Tangui Barré and seven co-authors survey people with Parkinson's disease in France about medical cannabis and cannabidiol. Their survey was published in twenty twenty-four. Cannabis products might ease symptoms, but trial results conflict, and French law keeps cannabis illegal outside a narrow experiment that excludes this disease.

CBD products, by contrast, are legal and widely sold. The nationwide online survey asked patients how acceptable they find therapeutic cannabis and CBD. It also probed knowledge, information hunting, and barriers to self-medicating. Statistical models linked traits with acceptance levels. The authors aim to inform whether medical cannabinoids deserve a formal place among Parkinson's treatment options in France.

Catalog record

CREATORTangui Barré, Géraldine Cazorla, Vincent Di Beo, Fabienne Lopez, Lise Radoszycki, Gwenaëlle Maradan, Christelle Baunez, Patrizia Carrieri
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE41 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11647636

Browse the full library · About the Tower of Babel